---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-173338"
form_type: "8-K"
ticker: "BNTC"
cik: "0001808898"
company_name: "Benitec Biopharma Inc."
filed_at: "2024-07-01T23:59:59+00:00"
generated_at: "2026-06-01T00:06:11.210765+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Benitec appoints Kishen Mehta to board; Suvretta Capital portfolio manager

## Summary
- Appointed as Class I director effective June 26, 2024, term through 2026 annual meeting.
- Mehta is portfolio manager at Suvretta Capital, which led $40M PIPE financing in April 2024.
- Will serve on Nominating and Corporate Governance Committee; board deemed him independent.
- Also serves on Biohaven Pharmaceuticals board; 15+ years healthcare investing experience.
- Appointment follows Board Designation Agreement with Suvretta disclosed in prior 8-K.

## SEC filing metadata
- accession: 0001193125-24-173338
- form_type: 8-K
- ticker: BNTC
- cik: 0001808898
- company_name: Benitec Biopharma Inc.
- filed_at: 2024-07-01T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1808898/000119312524173338/0001193125-24-173338-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1808898/000119312524173338/d853226d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-173338
- JSON: https://secwatch.observer/filing/0001193125-24-173338.json
- Plain text: https://secwatch.observer/filing/0001193125-24-173338.txt

## Source-grounded claims
- claim_id: e17a3d849e
  claim: Kishan Mehta was appointed as Director at Benitec Biopharma Inc..
  evidence_excerpt: On June 26, 2024, the Board of Directors (the “Board”) of Benitec Biopharma Inc. (the “Company”) appointed Kishan (“Kishen”) Mehta to serve as a director of the Board, effective as of June 26, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1808898/000119312524173338/0001193125-24-173338-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.